Wednesday, April 12, 2023 2:15:48 AM
What does bother me is this notion of some who say revive has the great drug worth millions and the same folks say the fda will never approve. I’ve been very vocal about that. And why I don’t invest more in this pos.
Hence I’ve said for months if this is the case then it’s MFs responsibility to unlock shareholder value thru some partnership with a BP. I suppose we wait and see. It’s outcome #4 from the last PR. For my part I have doubts about the drug but that’s because of the pps and poor results with FDA process make it unlikely a partnership will emerge. Thankfully I’m only out about 1200 on paper actually a little less since the flip I did a couple weeks back
Of course I hope I’m wrong about the drug and ability to partner.
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM